SANOFI-AVENTIS IRELAND LIMITED

Sanofi‑Aventis Ireland Limited is an R&D‑driven, AI‑powered biopharmaceutical company dedicated to improving people’s lives through innovative medicines and vaccines. Leveraging deep scientific expertise and advanced digital technologies, the firm develops treatments across a broad therapeutic portfolio that includes immunology, neurology, oncology, rare diseases and vaccines.

Sanofi’s activities span the full drug‑development continuum – from discovery and clinical trials (including investigator‑sponsored studies) to manufacturing, supply and patient‑focused services such as disease education and safe medication use. The company also pursues external innovation partnerships in Europe, North America and China, and offers out‑licensing opportunities for its technology platforms.

A strong emphasis on sustainability, equitable healthcare access and health‑system resilience underpins its operations, while robust governance structures ensure responsible business conduct. Sanofi‑Aventis Ireland serves patients, healthcare providers, research collaborators and investors, aiming to deliver breakthrough therapies that enable individuals to focus on what matters most.